|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2002-5-14
|
|
pubmed:abstractText |
Plasma level of B-type natriuretic peptide is a sensitive marker of left ventricular dysfunction and the level is markedly elevated in patients with hypertrophic obstructive cardiomyopathy. Percutaneous transluminal septal myocardial ablation, a catheter-based treatment of hypertrophic obstructive cardiomyopathy, has been widely used as a new therapeutic option for the disease. This study was designed to evaluate clinical implications of natriuretic peptides after the new treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0167-5273
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
83
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
151-8
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12007687-Adolescent,
pubmed-meshheading:12007687-Aged,
pubmed-meshheading:12007687-Analysis of Variance,
pubmed-meshheading:12007687-Atrial Natriuretic Factor,
pubmed-meshheading:12007687-Biological Markers,
pubmed-meshheading:12007687-Calcium-Calmodulin-Dependent Protein Kinases,
pubmed-meshheading:12007687-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:12007687-Catheter Ablation,
pubmed-meshheading:12007687-Creatine Kinase,
pubmed-meshheading:12007687-Creatine Kinase, MB Form,
pubmed-meshheading:12007687-Female,
pubmed-meshheading:12007687-Humans,
pubmed-meshheading:12007687-Isoenzymes,
pubmed-meshheading:12007687-Linear Models,
pubmed-meshheading:12007687-Male,
pubmed-meshheading:12007687-Middle Aged,
pubmed-meshheading:12007687-Postoperative Period,
pubmed-meshheading:12007687-Probability,
pubmed-meshheading:12007687-Prognosis,
pubmed-meshheading:12007687-Prospective Studies,
pubmed-meshheading:12007687-Sensitivity and Specificity
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation.
|
|
pubmed:affiliation |
Department of Cardiovascular Medicine, Kumamoto University School of Medicine, 1-1-1 Honjo, Kumamoto 860-8556, Japan.
|
|
pubmed:publicationType |
Journal Article
|
